Work

Immune checkpoint inhibitor-related thrombocytopenia: Incidence, risk factors, and effect on overall survival.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.e14549

Authors: Tyler Haddad, Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns, Madison Grogan, Gabrielle Lopez, Abdul Miah, Lai Wei, Gabriel Tinoco, Brian P Riesenberg, Zihai Li, Erin Marie Bertino, Kari Lynn Kendra, Gregory Alan Otterson, Carolyn J Presley, Dwight Hall Owen

Institutions: The Ohio State University, The Ohio State University Wexner Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Medical University of South Carolina, MUSC Hollings Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3172274178

Cites:

Cited by:

Related to: 10